Search Tag: ExThera Medical

Fresenius Medical Care Expands Critical Care Offering With ExThera Medical’s Seraph 100 Adsorber

2021 07 Jan

Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, will offer the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation in several European countries as of now. Both companies have signed a co-marketing and distribution agreement, effective in January 2021 and... Read more

Mother Nature’s Assistant: Why Glycocalyx Replacement Therapy is the Future of Medicine

2021 14 Jan

Presenters: Professor Herwig Gerlach  (Department for Anesthesia, Intensive Care Medicine and Pain Management, Vivantes - Klinikum Neukoelln, Berlin, Germany) Doctor Lakhmir Chawla  (Veterans Affairs Medical Center, San Diego, CA, USA) Find ExThera Medical on Social media     Read more

More Than Pathogen Reduction: Seraph 100 In COVID-19 Patients

2020 10 Nov

Panelists: Professor Jan Kielstein  (Klinikum Braunschweig, Germany)  Doctor Julius Schmidt  (Hannover Medical School, Germany)  Doctor Steven Stogner  (Forrest General Hospital in Hattiesburg, Mississippi, USA)  Doctor Brian Rifkin  (Forrest General Hospital in Hattiesburg, Mississippi, USA) Find ExThera Medical On Social... Read more

Michael Porter Of Harvard Business School Has Joined The Board Of Directors Of Exthera Medical

2020 29 Sep

Michael Porter, Ph.D., has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company focused on the therapeutic reduction of drug-resistant pathogens and sepsis mediators in whole blood. ExThera’s  Seraph® 100 Microbind® Affinity Blood Filter  (Seraph 100) has a CE Mark in Europe for the treatment... Read more

DOD to Fund a Clinical Trial of COVID-19 Treatment with ExThera’s Seraph 100 Blood Filter

2020 09 Jun

After encouraging preliminary results in the treatment of critically-ill COVID-19 patients at a military hospital in the United States and fourteen other hospitals in Europe, the Department of Defense has selected the Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) as one of its main interventions in a pivotal, US-based randomized controlled... Read more

FDA Grants ExThera’s Seraph-100 Blood Filter Emergency Use Authorization for COVID-19

2020 17 Apr

After promising COVID-19 treatments in Germany, France, Italy, Spain and the USA, ExThera Medical ’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has been granted Emergency Use Authorization by the Food and Drug Administration (FDA). This approval comes soon after first use of the device to treat COVID-19 patients in Europe and in... Read more

ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients

2020 26 Mar

Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA. Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical... Read more